Company intelligence / Profile preview

Institute of Immunology

Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Institute of Immunology manufactures and sells diagnostic reagents, monoclonal antibodies, and antigens, produces genetically engineered animals and cells, and develops unique animal models (notably for in vivo antibody drug evaluation). They have decades of operational history and support life science R&D, including preclinical models.

Therapeutic areas: OncologyInfectious DiseasesImmunology
Modalities: Monoclonal antibodyRecombinant proteinCell therapyAnimal modeliPS cell derived therapyDiagnostic reagents
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Institute of Immunology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institute of Immunology.

Explore the full profile